Cargando…
Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A(2)α via AKT in prostate cancer cells
Aberrant increase in pAKT, due to a gain-of-function mutation of PI3K or loss-of-function mutation or deletion of PTEN, occurs in prostate cancer and is associated with poor patient prognosis. Cytosolic phospholipase A(2)α (cPLA(2)α) is a lipid modifying enzyme by catalyzing the hydrolysis of membra...
Autores principales: | Vignarajan, Soma, Xie, Chanlu, Yao, Mu, Sun, Yuting, Simanainen, Ulla, Sved, Paul, Liu, Tao, Dong, Qihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171630/ https://www.ncbi.nlm.nih.gov/pubmed/25026288 |
Ejemplares similares
-
Targeting cytosolic phospholipase A(2) α in colorectal cancer cells inhibits constitutively activated protein kinase B (AKT) and cell proliferation
por: Zheng, Zhong, et al.
Publicado: (2014) -
Targeting of cytosolic phospholipase A(2)α impedes cell cycle re-entry of quiescent prostate cancer cells
por: Yao, Mu, et al.
Publicado: (2015) -
Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions
por: Boi, Roberto, et al.
Publicado: (2022) -
Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
por: Linkous, Amanda G., et al.
Publicado: (2010) -
Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity
por: Qasem, Hanan, et al.
Publicado: (2017)